(1999; 61 pages) [French] [Spanish]
Counterfeit Drugs. Guidelines for the development of measures to combat counterfeit drugs
Guidelines for the development
of measures to combat
Department of Essential Drugs and
World Health Organization
ORGANISATION MONDIALE DE LA SANTE
This document has been prepared under the auspices of the DMP-DAP Joint Project on Counterfeit Drugs which was administered by the World Health Organization Division of Drug Management and Policies (DMP) and the Action Programme on Essential Drugs (DAP) from 1995 to 1997. With effect from January 1999, the Department of Essential Drugs and Other Medicines Department (EDM) includes the former DAP and most components of DMP.
©World Health Organization (1999)
This document is not a formal publication of the World Health Organization (WHO) and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced, translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes.
The view expressed in documents by named authors are solely the responsibility of those authors.